Aptus Capital Advisors, LLC
- SEC CIK
- 0001664193
- Latest filing
- Aug 12, 2026
SEEL holding history
Seelos Therapeutics, Inc. in every 13F filed by Aptus Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SEEL overviewAll 13F holders of SEELFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −10,472−100.0% | Sold out | Holders |
| Q2 2023 | 10,472 | $12.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,472 | $7.24K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,472 | $7.11K | <0.1% | +300+2.9% | Added | Holders |
| Q3 2022 | 10,172 | $10.0K | <0.1% | +10,172 | New | Holders |